Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
,
Founded in 2011
1-10 employees
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
Company Information
- Industry
- Company Type
- Public Company
- Founded
- 2011
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- Modus Therapeutics AB Stockholm Stockholm
- City
- Region
- Postal Code
- 111 22
- Country
Web Presence
Websitemodustx.com
LinkedIn0 followers